Bayer Korea Denies Allegation Made by Korea Pharmaceutical Association

Published: 2005-03-29 07:00:00

Updated: 2005-03-29 07:00:00

In response to the recent discovery on the broken tablets of Caldivita, an over-the-counter (OTC) calcium supplement marketed by Bayer Korea, the company stated that the allegations made by the Korea Pharmaceutical Association (KPA) are not reflective of the company policy and the actual practice...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK